SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹143 Cr | ₹130 Cr | ₹196 Cr | ₹168 Cr | ₹97 Cr |
What is the latest Total Non-Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹143 Cr |
| Mar2024 | ₹130 Cr |
| Mar2023 | ₹196 Cr |
| Mar2022 | ₹168 Cr |
| Mar2017 | ₹97 Cr |
How is Total Non-Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹143 Cr | 10.34 | |
| Mar2024 | ₹130 Cr | -33.78 | |
| Mar2023 | ₹196 Cr | 16.45 | |
| Mar2022 | ₹168 Cr | 72.96 | |
| Mar2017 | ₹97 Cr | - | |
Compare Total Non-Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,327.3 Cr | 2.2% | 3.4% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.2% |
3.4% |
-16.3% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses